Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.

Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.

Item
http://www.wikidata.org/entity/Q34560235
Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature.The role of the toxicologic pathologist in the biopharmaceutical industry.Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice.Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals.Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity.
P2860

Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.

Item
http://www.wikidata.org/entity/Q34560235
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Application of genetically alt ...... in pharmaceutical development.
@ast
Application of genetically alt ...... in pharmaceutical development.
@en
Application of genetically alt ...... in pharmaceutical development.
@nl
type
label
Application of genetically alt ...... in pharmaceutical development.
@ast
Application of genetically alt ...... in pharmaceutical development.
@en
Application of genetically alt ...... in pharmaceutical development.
@nl
prefLabel
Application of genetically alt ...... in pharmaceutical development.
@ast
Application of genetically alt ...... in pharmaceutical development.
@en
Application of genetically alt ...... in pharmaceutical development.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Application of genetically alt ...... in pharmaceutical development.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698